BOSTON, Massachusetts, October 29, 2024—Today, S2N Health and Healthcare Inroads (“HCIR”) announced their collaboration on supporting MedTech innovators and investors with an extended range of advisory services and market intelligence to maximize the impact for patients, providers, and companies. HCIR’s team brings to S2N its expertise in clinical trial design and implementation, regulatory, coverage, and reimbursement, along with deep knowledge on generating value for health systems. S2N provides HCIR with access to its RepSignal market intelligence platform and commercial expertise to deliver tailored strategies and actionable insights at the HCP, facility, health system, and market level.

Leadership from HCIR and S2N Health will be attending the upcoming VIVA (Vascular InterVentional Advances) conference in Las Vegas, November 3–6, where they will be meeting with many innovative and market-leading companies delivering novel endovascular solutions to advance patient care.

About Healthcare Inroads (HCIR)
Healthcare Inroads is a partnership of seasoned clinicians and allied specialists, including experts in regulatory, engineering, marketing, reimbursement, finance, and value analysis, who understand what brings value to healthcare systems, hospitals, and GPOs. Our experience enables medtech companies, healthcare delivery systems, and investors to accelerate and maximize their goals. For more information, visit HCIR.io.

About S2N Health
Since 2011, S2N Health has been a leader in driving market success for medtech companies, providing data-driven commercial strategies and market insights to over 100 organizations—from start-ups to global enterprises. With the power of advanced analytics and deep CRM integration, S2N Health’s AI-powered market intelligence platform RepSignal delivers actionable market and customer intelligence that accelerates go-to-market success and revenue growth. To learn more, visit s2nhealth.com.